GANYMED PHARMACEUTICALS AG / ASTELLAS PHARMA INC. / MIG FONDS / FUTURE CAPITAL AG / ATS BETEILIGUNGSVERWALTUNG GMBH / Acquisition / Private / £395m

Synopsis

Acquisition by Astellas Pharma of Ganymed Pharmaceuticals, a Germany-based pharmaceutical company engaged in developing monoclonal antibody therapeutics against solid tumors

Principals

target

Ganymed Pharmaceuticals

bidder

Astellas Pharma

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (1)

christoph w. g. engeler

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 16.01 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy